A Single Administration of the Cytolytic CD38 Antibody TAK-079 to Healthy Subjects: Tolerability, Pharmacokinetics and Pharmacodynamics
Fedyk, Eric Robert, Berg, Deborah, Smithson, Glenda, Estevam, Jose, Mclean, Lachy, Allikmets, Kristina, Palumbo, Antonio
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article
The Binding of CD38 Therapeutics to Red Blood Cells and Platelets Subverts Depletion of Target Cells
Fedyk, Eric Robert, Idamakanti, Neeraja, Chen, Jia, Estevam, Jose, Hernandez, Vivian, Wagoner, Matthew, Carsillo, Mary, Berg, Deborah, Allikmets, Kristina, Lahu, Gezim, Palumbo, Antonio
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
Preliminary Results from a Phase 1b Study of TAK-079, an Investigational Anti-CD38 Monoclonal Antibody (mAb) in Patients with Relapsed/ Refractory Multiple Myeloma (RRMM)
Krishnan, Amrita Y., Patel, Krina K., Hari, Parameswaran, Jagannath, Sundar, Niesvizky, Ruben, Silbermann, Rebecca W., Berg, Deborah, Lin, Jianchang, Fedyk, Eric Robert, Palumbo, Antonio, Stockerl-Goldstein, Keith E.
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
Combination therapies using anti-CD38 antibodies
ALLIKMETS, KRISTINA, FEDYK, ERIC ROBERT, BERG, DEBORAH, PALUMBO, ANTONIO
Year of Publication 01.04.2021
Get full text
Year of Publication 01.04.2021
Patent